A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer
Interventions: DIAGNOSTIC_TEST: ABY-PET
Sponsor: Henrik Lindman
Collaborators: Roche Pharma AG|Swedish Cancer Society|Affibody|Swedish Breast Cancer Group